In contrast, the mortality of hematological malignancies (e.g., multiple myeloma, follicular and non-Hodgkin lymphoma, and chronic myelogenous leukemia) was not associated with CNA of IFN gene cluster and skin cancer had limited power. This evidence concerns the gene IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive.